ZA201404920B - Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants - Google Patents

Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants

Info

Publication number
ZA201404920B
ZA201404920B ZA2014/04920A ZA201404920A ZA201404920B ZA 201404920 B ZA201404920 B ZA 201404920B ZA 2014/04920 A ZA2014/04920 A ZA 2014/04920A ZA 201404920 A ZA201404920 A ZA 201404920A ZA 201404920 B ZA201404920 B ZA 201404920B
Authority
ZA
South Africa
Prior art keywords
osteopontin
variants
suppression
prevention
compositions containing
Prior art date
Application number
ZA2014/04920A
Other languages
English (en)
Inventor
Serena Anja
Langborg Wejse Peter
R Rittling Susan
Original Assignee
Forsyth Dental Infirmary For Children (D B A The Forsyth Institute)
Arla Foods Amba Co-Operative Soc With Limited Liability Organised And Existing Under The Laws Of Den
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forsyth Dental Infirmary For Children (D B A The Forsyth Institute), Arla Foods Amba Co-Operative Soc With Limited Liability Organised And Existing Under The Laws Of Den filed Critical Forsyth Dental Infirmary For Children (D B A The Forsyth Institute)
Publication of ZA201404920B publication Critical patent/ZA201404920B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
ZA2014/04920A 2011-12-07 2014-07-04 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants ZA201404920B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161567899P 2011-12-07 2011-12-07
US201261673912P 2012-07-20 2012-07-20
EP12177329 2012-07-20
PCT/US2012/068628 WO2013086459A1 (en) 2011-12-07 2012-12-07 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants

Publications (1)

Publication Number Publication Date
ZA201404920B true ZA201404920B (en) 2015-12-23

Family

ID=48574961

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/04920A ZA201404920B (en) 2011-12-07 2014-07-04 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants

Country Status (12)

Country Link
US (1) US20150344534A1 (enExample)
EP (1) EP2788015A1 (enExample)
JP (1) JP2015500836A (enExample)
KR (1) KR20140104474A (enExample)
CN (1) CN104080472A (enExample)
AR (1) AR089136A1 (enExample)
AU (1) AU2012347468A1 (enExample)
BR (1) BR112014013565A2 (enExample)
CA (1) CA2858379A1 (enExample)
EA (1) EA201491010A1 (enExample)
WO (1) WO2013086459A1 (enExample)
ZA (1) ZA201404920B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX369925B (es) 2013-07-05 2019-11-25 Arla Foods Amba Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.
EP4326758A4 (en) * 2021-04-20 2025-03-19 University of Cincinnati A vaccine adjuvant for infectious diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888552A (en) * 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
IL106576A (en) * 1992-08-13 2000-08-13 Immunotec Res Corp Ltd Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer
CA2370129A1 (en) * 1999-04-15 2000-10-26 Children's Medical Center Corporation Methods and compositions for modulating an immune response
US7259243B2 (en) 2000-01-07 2007-08-21 Arla Foods Amba Process for isolation of osteopontin from milk
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
EP1667537B1 (en) * 2003-09-18 2013-11-06 Arla Foods Amba Infant formula
SM200600031B (it) * 2006-10-06 2009-05-11 Gianluca Mech Integratore alimentare con attivatore proteico
DK2201138T3 (en) * 2007-10-16 2015-05-18 Ventana Med Syst Inc GRADING, STAGE DETERMINATION AND FORECAST OF CANCER USING osteopontin-C

Also Published As

Publication number Publication date
KR20140104474A (ko) 2014-08-28
WO2013086459A1 (en) 2013-06-13
EA201491010A1 (ru) 2015-01-30
CA2858379A1 (en) 2013-06-13
US20150344534A1 (en) 2015-12-03
AU2012347468A1 (en) 2014-06-26
CN104080472A (zh) 2014-10-01
EP2788015A1 (en) 2014-10-15
BR112014013565A2 (pt) 2019-09-24
AR089136A1 (es) 2014-07-30
JP2015500836A (ja) 2015-01-08

Similar Documents

Publication Publication Date Title
SG10201509279QA (en) Compositions and methods for the prevention and treatment of cancer
EP2675471A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
IL241098B (en) Antimicrobial preparations and methods of using them
PL2532365T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi
PL2532743T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka
PL2643419T3 (pl) Kompozycje chlorotrifluoropropenu i heksafluorobutenu
PT2832365T (pt) Composição farmacêutica para o tratamento e/ou prevenção do cancro hepático
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
PL2740796T3 (pl) Kompozycja farmaceutyczna do leczenia nowotworu i/lub zapobiegania nowotworowi
PT2740794T (pt) Composição farmacêutica para o tratamento e/ou profilaxia de cancro
GB2494787B (en) Neuro-protective effects of adelostemma gracillimum and its isolated compounds
IL251083A0 (en) Compounds and preparations for the treatment of cancer
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
IL225488A0 (en) Compounds and methods for the treatment of hematological malignancies
ZA201308078B (en) Novel cephalosporin derivative and medical composition containing same
ZA201402820B (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
ZA201301936B (en) Methods and compositions for treatment of diabetes and dyslipidemia
PT2576782T (pt) Arnsi e utilização dos mesmos em métodos e composições para o tratamento e/ou prevenção de condições oculares
ZA201302952B (en) Fungicidal compositions and methods of use
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
ZA201407978B (en) Compositions and methods for the alteration of xlhed phenotypes
GB2490240B (en) Use of compositions for growth and vigour in vegetables
EP2649096A4 (en) HEMOGLOBIN COMPOSITIONS AND METHODS OF USE
PL2736328T3 (pl) Biocydowe kompozycje oraz sposoby stosowania
PL2736339T3 (pl) Biocydowe kompozycje oraz sposoby stosowania